Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 4,980,000 shares, a decline of 9.5% from the April 30th total of 5,500,000 shares. Based on an average daily volume of 510,400 shares, the […]
Shares of Harrow, Inc. (NASDAQ:HROW – Get Free Report) traded down 5.8% on Wednesday . The company traded as low as $17.45 and last traded at $17.49. 215,167 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 464,695 shares. The stock had previously closed at $18.56. Analyst Upgrades […]
Harrow, Inc. (NASDAQ:HROW – Free Report) – B. Riley dropped their Q2 2024 earnings per share (EPS) estimates for Harrow in a research report issued to clients and investors on Tuesday, May 14th. B. Riley analyst M. Mamtani now expects that the company will earn ($0.25) per share for the quarter, down from their previous […]
Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 30th, there was short interest totalling 5,500,000 shares, a decrease of 7.1% from the April 15th total of 5,920,000 shares. Based on an average daily trading volume, of 462,100 shares, the days-to-cover ratio […]
Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […]